Average Co-Inventor Count = 12.27
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (34 from 329 patents)
2. Mirati Therapeutics, Inc. (7 from 38 patents)
3. Eli Lilly and Company (6 from 4,442 patents)
4. Genentech, Inc. (4 from 3,221 patents)
5. Loxo Oncology, Inc. (3 from 34 patents)
6. Celgene Corporation (2 from 549 patents)
7. Genetech, Inc. (1 from 98 patents)
8. Fong, Kin Chiu (0 patent)
9. Sammond, Douglas Mccord (0 patent)
10. Xu, Rui (0 patent)
11. Mitchell, Ian S. (0 patent)
12. Bencsik, Josef R. (0 patent)
13. Wallace, Eli M. (0 patent)
14. Banka, Anna (0 patent)
15. Blake, James F. (0 patent)
40 patents:
1. 12180207 - Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases
2. 11998545 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
3. 11964989 - KRas G12D inhibitors
4. 11932633 - KRas G12C inhibitors
5. 11807651 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
6. 11648243 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
7. 11453683 - KRas G12D inhibitors
8. 11267812 - KRAS G12C inhibitors
9. 11098064 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile
10. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
11. 10953005 - Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
12. 10881652 - Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
13. 10766881 - 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
14. 10745419 - Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
15. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors